PBMs' Evolving Business Model Continues To Raise Costs On Patients
Lowering patients' drug costs requires reforms to the PBM market. These reforms should address PBMs' growing use of group purchasing organizations (GPOs).
(Forbes, 2025-11-18T18:54:54Z)